CompletedPhase 2ketamine

intrathecaم Ketamine, Morphine and Both for Lower Abdominal Cancer Surgery Pain

Sponsored by Assiut University

NCT ID
NCT02726828
Target Enrollment
90 participants
Start Date
2015-10
Est. Completion
2016-04

About This Study

this study investigates the analgesic efficacy and other possible effects of ketamine, morphine, and both together when administered intrathecally for control of postoperative pain following lower abdominal cancer surgeries.

Conditions Studied

Postoperative Pain

Interventions

  • intrathecal morphine
  • intrathecal ketamine
  • intrathecal morphine + ketamine

Eligibility

Age:30 Years - 50 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* American Society of Anesthesia (ASA) I-III patients.
* aged 30-50 years.
* scheduled for major abdominal cancer surgery.

Exclusion Criteria:

* Patients with a known allergy to the study drugs.
* significant cardiac, respiratory, renal or hepatic disease.
* coagulation disorders.
* infection at or near the site of intrathecal injection.
* drug or alcohol abuse.
* BMI \> 30 kg/m2.
* psychiatric illnesses that may interfere with perception and assessment of pain.

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source